CPC Subgroup Additional Only
A61L 2300/40 characterised by a specific therapeutic activity or mode of action
Full Title
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices > characterised by a specific therapeutic activity or mode of action
18 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61L 2300/402 Anaestetics, analgesics, e.g. lidocaine
- A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/41 Anti-inflammatory agents, e.g. NSAIDs
- A61L 2300/412 Tissue-regenerating or healing or proliferative agents
- A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A61L 2300/418 Agents promoting blood coagulation, blood-clotting agents, embolising agents
- A61L 2300/42 Anti-thrombotic agents, anticoagulants, anti-platelet agents
- A61L 2300/422 Anti-atherosclerotic agents
- A61L 2300/424 Anti-adhesion agents
- A61L 2300/426 Immunomodulating agents, i.e. cytokines, interleukins, interferons
- A61L 2300/428 Vitamins, e.g. tocopherol, riboflavin
- A61L 2300/43 Hormones, e.g. dexamethasone
- A61L 2300/432 Inhibitors, antagonists (A61L2300/402 - A61L2300/43 take precedence)
- A61L 2300/438 Antigens
- A61L 2300/44 Radioisotopes, radionuclides
- A61L 2300/442 Colorants, dyes
- A61L 2300/45 Mixtures of two or more drugs, e.g. synergistic mixtures
- A61L 2300/452 Lubricants